analysis of polygenic traits in rats and mice has been very useful for finding the approximate chromosomal locations of the genes causing quantitative phenotypic variation, so-called quantitative trait loci (QTL). Further localization of the causative genes and their ultimate identification has, however, proven to be slow and frustrating. A major technique for gene identification in such models utilizes series of congenic strains with progressively smaller chromosomal segments introgressed from one inbred strain into another inbred strain. Under the assumption that a single causative locus underlies a QTL, nested series of congenic strains were earlier suggested as an appropriate configuration for the congenic strains. It is now known that most QTL are compound, that is, the QTL signal is caused by clusters of loci where alleles exert positive, negative, and interactive effects on the trait in a given strain comparison. It is argued that in this situation an initial series of nonoverlapping contiguous congenic strains over a relatively large chromosomal region will lead to a better appreciation of the underlying complexity of the QTL and therefore more rapid gene identification. Examples from the literature where this strategy would be helpful, as well as a case where it would be potentially counterproductive, are given. quantitative trait loci; polygenic inheritance; Dahl rats; hypertension DISCOVERY OF THE MULTIPLE loci causing variation in quantitative traits is difficult because the phenotype of a quantitative trait does not uniquely predict the underlying causative genotypes. Considerable progress has been made in the theory and techniques for locating quantitative trait loci (QTLs) to regions of chromosomes in model organisms especially those using inbred strains with different quantitative phenotypes (2-4, 15, 16, 18, 22, 26, 30, 33). Much less effort has been given to the development of techniques to systematically identify the underlying genes (3, 29) . Considering the analysis of QTLs in rats and mice, the follow-up technique most often applied after locating a QTL in segregating populations (or by other techniques) is the construction of congenic strains. This involves the marker-assisted introgression of a large region of chromosome containing a QTL from one inbred (donor) strain into another inbred (recipient) strain by well-established techniques (14, 18, 31, 32) . The phenotype of the initial congenic strain is then compared with the recipient strain to establish that the congenic chromosomal segment in fact has an effect on the phenotype.
DISCOVERY OF THE MULTIPLE loci causing variation in quantitative traits is difficult because the phenotype of a quantitative trait does not uniquely predict the underlying causative genotypes. Considerable progress has been made in the theory and techniques for locating quantitative trait loci (QTLs) to regions of chromosomes in model organisms especially those using inbred strains with different quantitative phenotypes (2-4, 15, 16, 18, 22, 26, 30, 33) . Much less effort has been given to the development of techniques to systematically identify the underlying genes (3, 29) . Considering the analysis of QTLs in rats and mice, the follow-up technique most often applied after locating a QTL in segregating populations (or by other techniques) is the construction of congenic strains. This involves the marker-assisted introgression of a large region of chromosome containing a QTL from one inbred (donor) strain into another inbred (recipient) strain by well-established techniques (14, 18, 31, 32) . The phenotype of the initial congenic strain is then compared with the recipient strain to establish that the congenic chromosomal segment in fact has an effect on the phenotype.
The obvious follow-up technique to identify the gene(s) underlying the QTL congenic interval is to reduce the originally introgressed chromosomal segment by subsequent construction of congenic substrains derived from the original congenic interval, which may be 25-50 cM (or Mb) in size. It is this early stage of reducing the target region that has not received much theoretical consideration. In our view this accounts for the slow progress made in going from QTL to quantitative locus identification.
Originally we suggested the (admittedly obvious) method shown diagrammatically in Fig. 1 (24) . The figure uses blood pressure in rats, specifically inbred hypertensive rats, compared with an inbred normotensive strain, as an example. The example of blood pressure is used since our experience with it illustrates the problems in QTL analysis discussed below. In Fig. 1 the original congenic strain (strain 1) was produced by introgressing a segment of chromosome from a normotensive strain into the hypertensive strain. This resulted in a reduced blood pressure in strain 1 compared with the hypertensive strain. A series of hypothetical nested congenic substrains constructed from the original congenic strain are shown (Fig. 1,  strains 2-7 ). These are produced by crossing congenic strain 1 to the recipient (hypertensive) strain and then intercrossing the resultant F1 rats to make an F2 population. Animals carrying recombinant chromosomes in the F2 population are identified by genotyping, backcrossed to the recipient strain to duplicate the desired chromosome, which is then fixed in the homozygous state by further selective marker-assisted breeding. The strains thus produced are phenotyped, and as the introgressed region from the normotensive strain crosses the location of the QTL between strains 4 and 5 there is a step change in blood pressure. Thus the QTL is between markers D and E shown at the top of the Fig. 1 .
Conceptually this is easy, but in practice strain differences are not always so clear because of high phenotypic variability, especially with blood pressure (9) . Also the location of the QTL as the difference between two strains is not sufficient but has to be confirmed by constructing a shorter congenic strain just encompassing the interval D to E and comparing this to the hypertensive strain. If a phenotypic effect is still present then another iteration of congenic substrains in the interval D to E is invariably required to narrow the QTL interval enough for gene identification. More importantly it is now widely recognized that QTL regions identified in logarithm of the odds (LOD) plots of segregating populations (or by other means) are usually compound. Such regions can contain alleles with positive or negative effects at more than one locus in the QTL interval, and there may be interactions between loci in the QTL interval. Examples of these problems in our work with blood pressure were observed on chromosomes 1 (27), 2 (6), 3 (17), 5 (7), 9 (11), and 10( 28). Moreover, the QTL may not be anywhere near the LOD peak because of ghost peaks between QTLs (19, 20) . Such effects can certainly be dissected using the scheme in Fig. 1 , but it can be quite confusing, and consideration of a different approach is also warranted.
Given that the ultimate goal is to localize each causative locus within a large QTL region into a small congenic interval and that more than one such locus is likely in a large (or even a small) QTL region, it makes sense to start out making small congenic intervals earlier in the process. Figure 2 shows a hypothetical set of contiguous congenic substrains in a large QTL region that contains two causative loci acting additively where the donor allele at QTLa reduces blood pressure and the donor allele at QTLb increases blood pressure. In this situation it is immediately obvious that substrain 5 in Fig. 2 shows an augmented phenotypic effect due to QTLa because of the removal of the effect of QTLb; this is a significant advantage. There are examples in the literature of linked QTL with opposite effects on blood pressure (1, 23, 28) . In the case where QTLs a and b are additive in the same direction the effect of each will be smaller than the original congenic strain. In the case where QTLs a and b are nonadditive (they interact) it is likely that each would show up with weak phenotypic effects the sum of which is not the same as the original congenic. In this case construction of a double congenic from small nonoverlapping substrains could be done to prove an interaction as has been done for interacting loci that were on different chromosomes (25) . The point is that the strains for construction of a double congenic are likely to be immediately available.
One situation where the use of contiguous congenic strains is likely to fail is where there are two linked causative loci in a QTL region such that interacting alleles at both loci are required for an effect but that neither allele alone causes an effect. We observed this exact situation for blood pressure in Dahl S rats on chromosome 5 (7), and here the nested congenic strains worked eminently well. A counterexample is, however, also instructive. Initially we found a blood pressure QTL on chromosome 13 in Dahl rats using nested congenic strains (34) . Further analysis using nested strains proved futile (unpublished). Moreno et al. (21) made 23 (highly redundant overlapping) congenic strains covering all of rat chromosome 13, which revealed a complex genetic architecture consisting of four regions containing interacting alleles that influence blood pressure. In this case contiguous strains were successful at defining a complex architecture where nested strains failed. Other examples in Dahl S rats where the contiguous congenic strain construction would probably have been the better approach to unravel a complex genetic architecture (two or more underlying causative loci) are on chromosomes 1 (27), 2 (6), and 10 (8). For didactic purposes Fig. 2 has only two theoretical causative loci, but the usefulness of the contiguous approach is enhanced where there are three or more causative loci underlying the QTL. Our experience is that there are always at least two.
It is rational to conclude that the best method to apply to an initial round of congenic strains depends on the underlying complex architecture of the QTL. Since this is unknown a priori, there is risk with either method. The example on chromosome 5 above is rare in our experience; thus the use of contiguous congenic strains in a large QTL region early in an analysis merits consideration.
The barrier to the analysis in Fig. 2 is of course the construction of the contiguous congenic substrains. The idealized strains in Fig. 2 in reality would be overlapping in some places and might have gaps between strains in other places. Overlaps and gaps should be minimized. As long as the gaps were not too extensive the chance of missing a QTL would not be inordinate. In any case the substrains in Fig. 2 can be constructed from the recombinant chromosomes that are generated in the initial phase of producing nested recombinant chromosomal segments, i.e., those shown in Fig. 1 . Typically these are produced in an F2 population of ϳ200 rats derived from crossing the initial congenic strain with the recipient strain. It is emphasized that it is not necessary to construct (or phenotype) the congenic strains in Fig. 1 to make the strains in Fig. 2 ; it is only necessary to obtain the recombinant chromosomes and to work with them in a backcross to the recipient strain (see below). In Fig. 1 only nested fragments starting at the left of the diagram are shown, but of course similar fragments starting from the right of the figure will also be generated. Thus in the initial screen the end fragments for generating congenic strains 2 and 8 in Fig. 2 should easily be obtained in the F2 population and/or in the following steps. It is, therefore, only necessary to consider further how to generate recombinant fragments for the construction of the internal substrains 3-7 in Fig. 2 . For example an F2 animal carrying the recombinant chromosome 2 in Fig. 1 is backcrossed to the recipient strain, and crossovers at markers E, F, and G are evaluated to generate the recombinant fragment used in constructing substrain 3 in Fig. 2 . If the region spanned by markers E, F, and G were (for example) 4 cM, then four crossovers per 100 meioses would be expected in that region. Thus screening 100 backcross animals should yield appropriate recombinants for constructing substrain 3 in Fig. 2 . Similarly recombinant chromosome 3 in Fig. 1 is used to generate substrain 4 of Fig. 2 , etc.
Consideration should also be given as to how the statistical analysis of the phenotypes (blood pressure) of the congenic strains generated in Fig. 2 should proceed. All nine strains in Fig. 2 can be compared by a one-way analysis of variance (ANOVA) with blocks. For example, if one wanted 20 rats to be phenotyped for each strain it would be difficult to raise and take blood pressure on all 180 rats concomitantly. Ten statistical blocks of 18 rats (2 rats per strain for 9 strains) could be phenotyped separately and analyzed by an ANOVA removing the differences (if any) between blocks, followed by strain comparisons. The latter can place the strains into subsets with the same blood pressure, and of course pair-wise strain comparisons are also appropriate. Figure 2 is meant to be used early in the congenic analysis in a relatively large region (25 cM/Mb) and should replace initial construction of the nested congenic strains shown in Fig.  1 . It can certainly work for smaller regions, but the smaller the region the larger the populations that need to be screened for crossovers. Substrains in the range of a few cM/Mb with phenotypic effects can be reduced further by screening a large F2 population (Ͼ500 rats) to find recombinant chromosomes in a small region. This is essentially the procedure in Fig. 1 now applied to a much smaller region. Given the current state of genomics, if a small enough congenic segment still causing a phenotypic effect is obtained, it is likely that causative genes can be identified. Small congenic regions in the range of a few hundred kilobase pairs have been achieved for blood pressure QTL (5, 10 -13) . Verification studies can follow with genetically-engineered "knock-in" or "knock-out" models as appropriate for each locus.
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